| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:51 UTC |
|---|
| Update Date | 2022-03-07 02:51:52 UTC |
|---|
| HMDB ID | HMDB0015139 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Ganciclovir |
|---|
| Description | Ganciclovir is only found in individuals that have used or taken this drug. It is an acyclovir analog that is a potent inhibitor of the Herpesvirus family including cytomegalovirus. Ganciclovir is used to treat complications from AIDS-associated cytomegalovirus infections. [PubChem]Ganciclovir's antiviral activity inhibits virus replication. This inhibitory action is highly selective as the drug must be converted to the active form by a virus-encoded cellular enzyme, thymidine kinase (TK). TK catalyzes phosphorylation of ganciclovir to the monophosphate, which is then subsequently converted into the diphosphate by cellular guanylate kinase and into the triphosphate by a number of cellular enzymes. In vitro, ganciclovir triphosphate stops replication of herpes viral DNA. When used as a substrate for viral DNA polymerase, ganciclovir triphosphate competitively inhibits dATP leading to the formation of 'faulty' DNA. This is where ganciclovir triphosphate is incorporated into the DNA strand replacing many of the adenosine bases. This results in the prevention of DNA synthesis, as phosphodiester bridges can longer to be built, destabilizing the strand. Ganciclovir inhibits viral DNA polymerases more effectively than it does cellular polymerase, and chain elongation resumes when ganciclovir is removed. |
|---|
| Structure | NC1=NC2=C(N=CN2COC(CO)CO)C(=O)N1 InChI=1S/C9H13N5O4/c10-9-12-7-6(8(17)13-9)11-3-14(7)4-18-5(1-15)2-16/h3,5,15-16H,1-2,4H2,(H3,10,12,13,17) |
|---|
| Synonyms | | Value | Source |
|---|
| 2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol | ChEBI | | 2-Amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one | ChEBI | | 2-Amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one | ChEBI | | 2-Amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol | ChEBI | | 2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one | ChEBI | | 2-Amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone | ChEBI | | 9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine | ChEBI | | 9-(1,3-DIHYDROXY-propoxymethane)guanine | ChEBI | | 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine | ChEBI | | GA2 | ChEBI | | Ganciclovirum | ChEBI | | Gancyclovir | ChEBI | | Cytovene | Kegg | | Vitrasert | Kegg | | Zirgan | Kegg | | Ganciclovir sodium | HMDB | | BIOLF-62 | HMDB | | Ganciclovir, monosodium salt | HMDB |
|
|---|
| Chemical Formula | C9H13N5O4 |
|---|
| Average Molecular Weight | 255.2306 |
|---|
| Monoisotopic Molecular Weight | 255.096753929 |
|---|
| IUPAC Name | 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-1H-purin-6-one |
|---|
| Traditional Name | gancyclovir |
|---|
| CAS Registry Number | 82410-32-0 |
|---|
| SMILES | NC1=NC2=C(N=CN2COC(CO)CO)C(=O)N1 |
|---|
| InChI Identifier | InChI=1S/C9H13N5O4/c10-9-12-7-6(8(17)13-9)11-3-14(7)4-18-5(1-15)2-16/h3,5,15-16H,1-2,4H2,(H3,10,12,13,17) |
|---|
| InChI Key | IRSCQMHQWWYFCW-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as hypoxanthines. Hypoxanthines are compounds containing the purine derivative 1H-purin-6(9H)-one. Purine is a bicyclic aromatic compound made up of a pyrimidine ring fused to an imidazole ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Imidazopyrimidines |
|---|
| Sub Class | Purines and purine derivatives |
|---|
| Direct Parent | Hypoxanthines |
|---|
| Alternative Parents | |
|---|
| Substituents | - 6-oxopurine
- Hypoxanthine
- Aminopyrimidine
- Pyrimidone
- Glycerolipid
- N-substituted imidazole
- Pyrimidine
- Azole
- Imidazole
- Heteroaromatic compound
- Vinylogous amide
- Azacycle
- Primary amine
- Primary alcohol
- Organooxygen compound
- Organonitrogen compound
- Organic oxide
- Alcohol
- Organopnictogen compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Amine
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 250 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 11.6 g/L | Not Available | | LogP | -1.7 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 1.56 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.8594 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 5.53 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 233.0 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 612.6 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 291.4 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 30.8 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 168.6 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 75.6 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 348.5 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 271.0 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 867.4 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 637.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 55.1 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 870.8 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 192.3 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 209.7 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 780.8 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 387.2 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 346.8 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Ganciclovir,1TMS,isomer #1 | C[Si](C)(C)OCC(CO)OCN1C=NC2=C1N=C(N)[NH]C2=O | 2543.6 | Semi standard non polar | 33892256 | | Ganciclovir,1TMS,isomer #2 | C[Si](C)(C)NC1=NC2=C(N=CN2COC(CO)CO)C(=O)[NH]1 | 2640.8 | Semi standard non polar | 33892256 | | Ganciclovir,1TMS,isomer #3 | C[Si](C)(C)N1C(N)=NC2=C(N=CN2COC(CO)CO)C1=O | 2690.4 | Semi standard non polar | 33892256 | | Ganciclovir,2TMS,isomer #1 | C[Si](C)(C)OCC(CO[Si](C)(C)C)OCN1C=NC2=C1N=C(N)[NH]C2=O | 2502.6 | Semi standard non polar | 33892256 | | Ganciclovir,2TMS,isomer #2 | C[Si](C)(C)NC1=NC2=C(N=CN2COC(CO)CO[Si](C)(C)C)C(=O)[NH]1 | 2524.6 | Semi standard non polar | 33892256 | | Ganciclovir,2TMS,isomer #3 | C[Si](C)(C)OCC(CO)OCN1C=NC2=C1N=C(N)N([Si](C)(C)C)C2=O | 2597.0 | Semi standard non polar | 33892256 | | Ganciclovir,2TMS,isomer #4 | C[Si](C)(C)N(C1=NC2=C(N=CN2COC(CO)CO)C(=O)[NH]1)[Si](C)(C)C | 2570.2 | Semi standard non polar | 33892256 | | Ganciclovir,2TMS,isomer #5 | C[Si](C)(C)NC1=NC2=C(N=CN2COC(CO)CO)C(=O)N1[Si](C)(C)C | 2664.2 | Semi standard non polar | 33892256 | | Ganciclovir,3TMS,isomer #1 | C[Si](C)(C)NC1=NC2=C(N=CN2COC(CO[Si](C)(C)C)CO[Si](C)(C)C)C(=O)[NH]1 | 2505.5 | Semi standard non polar | 33892256 | | Ganciclovir,3TMS,isomer #1 | C[Si](C)(C)NC1=NC2=C(N=CN2COC(CO[Si](C)(C)C)CO[Si](C)(C)C)C(=O)[NH]1 | 2708.3 | Standard non polar | 33892256 | | Ganciclovir,3TMS,isomer #1 | C[Si](C)(C)NC1=NC2=C(N=CN2COC(CO[Si](C)(C)C)CO[Si](C)(C)C)C(=O)[NH]1 | 3765.1 | Standard polar | 33892256 | | Ganciclovir,3TMS,isomer #2 | C[Si](C)(C)OCC(CO[Si](C)(C)C)OCN1C=NC2=C1N=C(N)N([Si](C)(C)C)C2=O | 2551.7 | Semi standard non polar | 33892256 | | Ganciclovir,3TMS,isomer #2 | C[Si](C)(C)OCC(CO[Si](C)(C)C)OCN1C=NC2=C1N=C(N)N([Si](C)(C)C)C2=O | 2635.6 | Standard non polar | 33892256 | | Ganciclovir,3TMS,isomer #2 | C[Si](C)(C)OCC(CO[Si](C)(C)C)OCN1C=NC2=C1N=C(N)N([Si](C)(C)C)C2=O | 3892.8 | Standard polar | 33892256 | | Ganciclovir,3TMS,isomer #3 | C[Si](C)(C)OCC(CO)OCN1C=NC2=C1N=C(N([Si](C)(C)C)[Si](C)(C)C)[NH]C2=O | 2532.9 | Semi standard non polar | 33892256 | | Ganciclovir,3TMS,isomer #3 | C[Si](C)(C)OCC(CO)OCN1C=NC2=C1N=C(N([Si](C)(C)C)[Si](C)(C)C)[NH]C2=O | 2848.8 | Standard non polar | 33892256 | | Ganciclovir,3TMS,isomer #3 | C[Si](C)(C)OCC(CO)OCN1C=NC2=C1N=C(N([Si](C)(C)C)[Si](C)(C)C)[NH]C2=O | 3665.6 | Standard polar | 33892256 | | Ganciclovir,3TMS,isomer #4 | C[Si](C)(C)NC1=NC2=C(N=CN2COC(CO)CO[Si](C)(C)C)C(=O)N1[Si](C)(C)C | 2608.0 | Semi standard non polar | 33892256 | | Ganciclovir,3TMS,isomer #4 | C[Si](C)(C)NC1=NC2=C(N=CN2COC(CO)CO[Si](C)(C)C)C(=O)N1[Si](C)(C)C | 2753.6 | Standard non polar | 33892256 | | Ganciclovir,3TMS,isomer #4 | C[Si](C)(C)NC1=NC2=C(N=CN2COC(CO)CO[Si](C)(C)C)C(=O)N1[Si](C)(C)C | 3730.2 | Standard polar | 33892256 | | Ganciclovir,3TMS,isomer #5 | C[Si](C)(C)N(C1=NC2=C(N=CN2COC(CO)CO)C(=O)N1[Si](C)(C)C)[Si](C)(C)C | 2685.2 | Semi standard non polar | 33892256 | | Ganciclovir,3TMS,isomer #5 | C[Si](C)(C)N(C1=NC2=C(N=CN2COC(CO)CO)C(=O)N1[Si](C)(C)C)[Si](C)(C)C | 2865.8 | Standard non polar | 33892256 | | Ganciclovir,3TMS,isomer #5 | C[Si](C)(C)N(C1=NC2=C(N=CN2COC(CO)CO)C(=O)N1[Si](C)(C)C)[Si](C)(C)C | 3693.3 | Standard polar | 33892256 | | Ganciclovir,4TMS,isomer #1 | C[Si](C)(C)OCC(CO[Si](C)(C)C)OCN1C=NC2=C1N=C(N([Si](C)(C)C)[Si](C)(C)C)[NH]C2=O | 2549.2 | Semi standard non polar | 33892256 | | Ganciclovir,4TMS,isomer #1 | C[Si](C)(C)OCC(CO[Si](C)(C)C)OCN1C=NC2=C1N=C(N([Si](C)(C)C)[Si](C)(C)C)[NH]C2=O | 2787.6 | Standard non polar | 33892256 | | Ganciclovir,4TMS,isomer #1 | C[Si](C)(C)OCC(CO[Si](C)(C)C)OCN1C=NC2=C1N=C(N([Si](C)(C)C)[Si](C)(C)C)[NH]C2=O | 3332.6 | Standard polar | 33892256 | | Ganciclovir,4TMS,isomer #2 | C[Si](C)(C)NC1=NC2=C(N=CN2COC(CO[Si](C)(C)C)CO[Si](C)(C)C)C(=O)N1[Si](C)(C)C | 2601.0 | Semi standard non polar | 33892256 | | Ganciclovir,4TMS,isomer #2 | C[Si](C)(C)NC1=NC2=C(N=CN2COC(CO[Si](C)(C)C)CO[Si](C)(C)C)C(=O)N1[Si](C)(C)C | 2703.6 | Standard non polar | 33892256 | | Ganciclovir,4TMS,isomer #2 | C[Si](C)(C)NC1=NC2=C(N=CN2COC(CO[Si](C)(C)C)CO[Si](C)(C)C)C(=O)N1[Si](C)(C)C | 3399.8 | Standard polar | 33892256 | | Ganciclovir,4TMS,isomer #3 | C[Si](C)(C)OCC(CO)OCN1C=NC2=C1N=C(N([Si](C)(C)C)[Si](C)(C)C)N([Si](C)(C)C)C2=O | 2652.4 | Semi standard non polar | 33892256 | | Ganciclovir,4TMS,isomer #3 | C[Si](C)(C)OCC(CO)OCN1C=NC2=C1N=C(N([Si](C)(C)C)[Si](C)(C)C)N([Si](C)(C)C)C2=O | 2862.9 | Standard non polar | 33892256 | | Ganciclovir,4TMS,isomer #3 | C[Si](C)(C)OCC(CO)OCN1C=NC2=C1N=C(N([Si](C)(C)C)[Si](C)(C)C)N([Si](C)(C)C)C2=O | 3327.6 | Standard polar | 33892256 | | Ganciclovir,5TMS,isomer #1 | C[Si](C)(C)OCC(CO[Si](C)(C)C)OCN1C=NC2=C1N=C(N([Si](C)(C)C)[Si](C)(C)C)N([Si](C)(C)C)C2=O | 2645.6 | Semi standard non polar | 33892256 | | Ganciclovir,5TMS,isomer #1 | C[Si](C)(C)OCC(CO[Si](C)(C)C)OCN1C=NC2=C1N=C(N([Si](C)(C)C)[Si](C)(C)C)N([Si](C)(C)C)C2=O | 2823.2 | Standard non polar | 33892256 | | Ganciclovir,5TMS,isomer #1 | C[Si](C)(C)OCC(CO[Si](C)(C)C)OCN1C=NC2=C1N=C(N([Si](C)(C)C)[Si](C)(C)C)N([Si](C)(C)C)C2=O | 3064.3 | Standard polar | 33892256 | | Ganciclovir,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(CO)OCN1C=NC2=C1N=C(N)[NH]C2=O | 2785.9 | Semi standard non polar | 33892256 | | Ganciclovir,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=NC2=C(N=CN2COC(CO)CO)C(=O)[NH]1 | 2868.3 | Semi standard non polar | 33892256 | | Ganciclovir,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N1C(N)=NC2=C(N=CN2COC(CO)CO)C1=O | 2883.3 | Semi standard non polar | 33892256 | | Ganciclovir,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(CO[Si](C)(C)C(C)(C)C)OCN1C=NC2=C1N=C(N)[NH]C2=O | 2949.5 | Semi standard non polar | 33892256 | | Ganciclovir,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=NC2=C(N=CN2COC(CO)CO[Si](C)(C)C(C)(C)C)C(=O)[NH]1 | 2970.4 | Semi standard non polar | 33892256 | | Ganciclovir,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OCC(CO)OCN1C=NC2=C1N=C(N)N([Si](C)(C)C(C)(C)C)C2=O | 3042.4 | Semi standard non polar | 33892256 | | Ganciclovir,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)N(C1=NC2=C(N=CN2COC(CO)CO)C(=O)[NH]1)[Si](C)(C)C(C)(C)C | 3002.2 | Semi standard non polar | 33892256 | | Ganciclovir,2TBDMS,isomer #5 | CC(C)(C)[Si](C)(C)NC1=NC2=C(N=CN2COC(CO)CO)C(=O)N1[Si](C)(C)C(C)(C)C | 3083.8 | Semi standard non polar | 33892256 | | Ganciclovir,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=NC2=C(N=CN2COC(CO[Si](C)(C)C(C)(C)C)CO[Si](C)(C)C(C)(C)C)C(=O)[NH]1 | 3159.2 | Semi standard non polar | 33892256 | | Ganciclovir,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=NC2=C(N=CN2COC(CO[Si](C)(C)C(C)(C)C)CO[Si](C)(C)C(C)(C)C)C(=O)[NH]1 | 3288.7 | Standard non polar | 33892256 | | Ganciclovir,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=NC2=C(N=CN2COC(CO[Si](C)(C)C(C)(C)C)CO[Si](C)(C)C(C)(C)C)C(=O)[NH]1 | 3796.1 | Standard polar | 33892256 | | Ganciclovir,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OCC(CO[Si](C)(C)C(C)(C)C)OCN1C=NC2=C1N=C(N)N([Si](C)(C)C(C)(C)C)C2=O | 3235.4 | Semi standard non polar | 33892256 | | Ganciclovir,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OCC(CO[Si](C)(C)C(C)(C)C)OCN1C=NC2=C1N=C(N)N([Si](C)(C)C(C)(C)C)C2=O | 3245.3 | Standard non polar | 33892256 | | Ganciclovir,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OCC(CO[Si](C)(C)C(C)(C)C)OCN1C=NC2=C1N=C(N)N([Si](C)(C)C(C)(C)C)C2=O | 3884.8 | Standard polar | 33892256 | | Ganciclovir,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OCC(CO)OCN1C=NC2=C1N=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[NH]C2=O | 3130.4 | Semi standard non polar | 33892256 | | Ganciclovir,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OCC(CO)OCN1C=NC2=C1N=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[NH]C2=O | 3417.9 | Standard non polar | 33892256 | | Ganciclovir,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OCC(CO)OCN1C=NC2=C1N=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[NH]C2=O | 3679.9 | Standard polar | 33892256 | | Ganciclovir,3TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)NC1=NC2=C(N=CN2COC(CO)CO[Si](C)(C)C(C)(C)C)C(=O)N1[Si](C)(C)C(C)(C)C | 3237.1 | Semi standard non polar | 33892256 | | Ganciclovir,3TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)NC1=NC2=C(N=CN2COC(CO)CO[Si](C)(C)C(C)(C)C)C(=O)N1[Si](C)(C)C(C)(C)C | 3324.3 | Standard non polar | 33892256 | | Ganciclovir,3TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)NC1=NC2=C(N=CN2COC(CO)CO[Si](C)(C)C(C)(C)C)C(=O)N1[Si](C)(C)C(C)(C)C | 3713.7 | Standard polar | 33892256 | | Ganciclovir,3TBDMS,isomer #5 | CC(C)(C)[Si](C)(C)N(C1=NC2=C(N=CN2COC(CO)CO)C(=O)N1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3254.5 | Semi standard non polar | 33892256 | | Ganciclovir,3TBDMS,isomer #5 | CC(C)(C)[Si](C)(C)N(C1=NC2=C(N=CN2COC(CO)CO)C(=O)N1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3408.2 | Standard non polar | 33892256 | | Ganciclovir,3TBDMS,isomer #5 | CC(C)(C)[Si](C)(C)N(C1=NC2=C(N=CN2COC(CO)CO)C(=O)N1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3651.3 | Standard polar | 33892256 | | Ganciclovir,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(CO[Si](C)(C)C(C)(C)C)OCN1C=NC2=C1N=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[NH]C2=O | 3306.7 | Semi standard non polar | 33892256 | | Ganciclovir,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(CO[Si](C)(C)C(C)(C)C)OCN1C=NC2=C1N=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[NH]C2=O | 3557.3 | Standard non polar | 33892256 | | Ganciclovir,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(CO[Si](C)(C)C(C)(C)C)OCN1C=NC2=C1N=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[NH]C2=O | 3536.9 | Standard polar | 33892256 | | Ganciclovir,4TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=NC2=C(N=CN2COC(CO[Si](C)(C)C(C)(C)C)CO[Si](C)(C)C(C)(C)C)C(=O)N1[Si](C)(C)C(C)(C)C | 3415.1 | Semi standard non polar | 33892256 | | Ganciclovir,4TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=NC2=C(N=CN2COC(CO[Si](C)(C)C(C)(C)C)CO[Si](C)(C)C(C)(C)C)C(=O)N1[Si](C)(C)C(C)(C)C | 3466.6 | Standard non polar | 33892256 | | Ganciclovir,4TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=NC2=C(N=CN2COC(CO[Si](C)(C)C(C)(C)C)CO[Si](C)(C)C(C)(C)C)C(=O)N1[Si](C)(C)C(C)(C)C | 3575.0 | Standard polar | 33892256 | | Ganciclovir,4TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OCC(CO)OCN1C=NC2=C1N=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)C2=O | 3400.7 | Semi standard non polar | 33892256 | | Ganciclovir,4TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OCC(CO)OCN1C=NC2=C1N=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)C2=O | 3582.9 | Standard non polar | 33892256 | | Ganciclovir,4TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OCC(CO)OCN1C=NC2=C1N=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)C2=O | 3514.3 | Standard polar | 33892256 | | Ganciclovir,5TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(CO[Si](C)(C)C(C)(C)C)OCN1C=NC2=C1N=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)C2=O | 3565.1 | Semi standard non polar | 33892256 | | Ganciclovir,5TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(CO[Si](C)(C)C(C)(C)C)OCN1C=NC2=C1N=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)C2=O | 3688.7 | Standard non polar | 33892256 | | Ganciclovir,5TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(CO[Si](C)(C)C(C)(C)C)OCN1C=NC2=C1N=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)C2=O | 3408.6 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Ganciclovir GC-MS (Non-derivatized) - 70eV, Positive | splash10-003r-9650000000-8833f26b2a4a485cc527 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Ganciclovir GC-MS (2 TMS) - 70eV, Positive | splash10-0uea-4944000000-abdc13da6e0d228949c8 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Ganciclovir GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Ganciclovir LC-ESI-QQ , negative-QTOF | splash10-0gb9-0090000000-b4bf1558f31e6cd80503 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ganciclovir LC-ESI-QQ , negative-QTOF | splash10-014i-1090000000-80a7b4d22e1375eb8a4d | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ganciclovir LC-ESI-QQ , negative-QTOF | splash10-000j-9610000000-c3053bd735d9f92930bf | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ganciclovir LC-ESI-QQ , negative-QTOF | splash10-007a-9300000000-392c976e03c2a82984cc | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ganciclovir LC-ESI-QQ , negative-QTOF | splash10-00di-9000000000-168468ed262e2df62267 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ganciclovir LC-ESI-QQ , positive-QTOF | splash10-0a4r-0490000000-0a16ac79577fd707fd15 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ganciclovir LC-ESI-QQ , positive-QTOF | splash10-0udi-0920000000-16d50b83e7be32f4db70 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ganciclovir LC-ESI-QQ , positive-QTOF | splash10-0udi-1900000000-2eca31ed3c60988970dc | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ganciclovir LC-ESI-QQ , positive-QTOF | splash10-0udu-2900000000-fd85740333fbb29714c8 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ganciclovir LC-ESI-QQ , positive-QTOF | splash10-01pc-3900000000-81b422bf6764161bcb0f | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ganciclovir LC-ESI-IT , positive-QTOF | splash10-0udi-0900000000-618946bbba03bdf5db19 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ganciclovir 10V, Positive-QTOF | splash10-0udi-0930000000-70cd640f0189ec01f99e | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ganciclovir 20V, Positive-QTOF | splash10-0udi-0900000000-fc49c7f073ae10ab487c | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ganciclovir 40V, Positive-QTOF | splash10-0udr-0900000000-d80c22cdcb2574987d4f | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ganciclovir 10V, Negative-QTOF | splash10-0udi-1590000000-0f6062547f6f0b5361fc | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ganciclovir 20V, Negative-QTOF | splash10-0udi-1950000000-44b53e03563a8182d288 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ganciclovir 40V, Negative-QTOF | splash10-0pbc-4900000000-7a563bb9b702e9ef5287 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ganciclovir 10V, Positive-QTOF | splash10-0udi-0930000000-8591208e148c4533f09f | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ganciclovir 20V, Positive-QTOF | splash10-0udi-0900000000-f2cc24b91d79a58f5388 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ganciclovir 40V, Positive-QTOF | splash10-000i-1900000000-ca0f90024b546ecff4a6 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ganciclovir 10V, Negative-QTOF | splash10-0udi-1290000000-33f6d44fd5c47d6bd926 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ganciclovir 20V, Negative-QTOF | splash10-0udi-0900000000-5e48c6b7e667862711a5 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ganciclovir 40V, Negative-QTOF | splash10-053u-5900000000-168c679102de3c71bc14 | 2021-10-11 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum |
|
|---|